Aptevo Therapeutics Inc.   NASDAQ (APVO)

13.07    $1.12   9.37%
At close   Friday, Nov 26 04:00 PM

Aptevo Therapeutics Inc. Chart

APVO Stock Price Today

Aptevo Therapeutics Inc. (APVO) stock rallied over 9.37% intraday to trade at $13.07 a share on NASDAQ. The stock opened with a gain of 7.95% at $12.90 and touched an intraday high of $14.10, rising 17.99% against the last close of $11.95. The stock went to a low of $11.26 during the session.

Stock Snapshot

11.95
Prev. Close
12.90
Open
71.10M
Market Cap
4.89M
Number of Shares
11.26
day Low
14.10
Day High
13.07
-
P/E ratio
1.79%
Free Float in %
-6.60
EPS (TTM)
1.49
Book Value per Share
9.58
Cash Flow per Share
7.61M
Volume

Aptevo Therapeutics Inc. Historical Data

DateOpenCloseDaily HighDaily LowVolume
2021-11-26$12.90$13.07$14.10$11.257,615,900
2021-11-24$12.41$11.95$15.33$10.8124,745,900
2021-11-23$9.51$17.03$22.08$8.36164,120,500
2021-11-22$7.41$6.48$7.69$6.38629,500
2021-11-19$8.07$7.30$8.52$7.20432,400
2021-11-18$10.07$8.10$10.49$7.78789,000
2021-11-17$9.58$10.02$10.05$9.4073,800
2021-11-16$9.85$9.58$10.25$9.40201,100
2021-11-15$11.48$9.72$11.60$9.50278,600
2021-11-12$12.92$11.64$13.28$11.55189,300
2021-11-11$13.20$12.75$13.85$12.4190,700

Contact Details

2401 4th Avenue
Suite 1050
Seattle, WA 98121
United States
http://www.aptevotherapeutics.com
206 838 0500

Company Information

Employees80
Beta6.73
Sales or Revenue11.00M
5Y Sales Change-33.70%
Fiscal Year Ends2020-12-30
SectorHealthcare
IndustryBiotechnology

About Company

Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1/1b clinical trial for acute myelogenous leukemia and myelodysplastic syndrome. The company's preclinical candidates also include ALG.APV-527, an investigational bispecific ADAPTIR candidate that features a mechanism of action to target 4-1BB (CD137) and 5T4, a tumor antigen expressed in various types of cancers; and APVO603, a dual agonist bispecific antibody to target 4-1BB and OX40. It is also developing APVO442, a bispecific candidate based on the ADAPTIR-FLEX platform technology to enhance biodistribution of drugs to PSMA positive tumors for treatment of prostate cancer; and other pre-clinical development stage therapeutics focused on hematologic and solid tumors. It has a collaboration and option agreement with Alligator Bioscience AB to develop ALG.APV-527. Aptevo Therapeutics Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.

Frequently Asked Questions

What is the current Aptevo Therapeutics Inc. (APVO) stock price?

Aptevo Therapeutics Inc. (NASDAQ: APVO) stock price is $13.07 as of the last check on Friday, Nov 26. During the trading session, APVO stock reached the peak price of $14.10 while $11.26 was the lowest point it dropped to.

APVO's industry and sector of operation?

The NASDAQ listed APVO is part of Biotechnology industry that operates in the broader Healthcare sector. Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States.

Who are the executives of APVO?

Mr. Marvin L. White
Pres, CEO & Director

Mr. Jeffrey G. Lamothe
Sr. VP, CFO & Treasurer

Dr. Jane A. Gross
Sr. VP & Chief Scientific Officer

Ms. Stacey Jurchison
Sr. Director of Investor Relations & Corp. Communications


What is the APVO stock price today?

APVO stock traded closed the last session at $13.07, which is $1.12 or 9.37% higher than its previous close of $11.95. APVO's current trading price is -74.74% lower than its 52-week high of $51.75 where as its distance from 52-week low of $6.38 is 104.86%.

How many employees does APVO have?

Number of APVO employees currently stands at 80. APVO operates from 2401 4th Avenue Suite 1050 Seattle, WA 98121 United States.

Link for APVO official website?


How do I contact APVO?

APVO could be contacted at 2401 4th Avenue Suite 1050 Seattle, WA 98121 United States, or at phone # 206 838 0500 and can also be accessed through its website: http://www.aptevotherapeutics.com

How many shares of APVO are traded daily?

APVO stock volume for the day was 7.61M shares while in the previous session number of APVO shares traded was 7.62M. The average number of APVO shares traded daily for last 3 months was 2.99M.

How much did APVO change today?

The percentage change in APVO stock occurred in the recent session was 9.37% while the dollar amount for the price change in APVO stock was $1.12.

What price range APVO stock been trading in?

In the recent session, the day high for APVO stock was $14.10 while the low for APVO stock touched on the day was $11.26.

What is the market cap of APVO currently?

The market value of APVO currently stands at $71.10M with its latest stock price at $13.07 and 4.89M of its shares outstanding.

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam